![Michael Overdorf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 989 828 $ al 31/05/2026
Michael Overdorf is Chief Business Officer & Executive Vice President at Annexon, Inc. since 2020.
Mr. Overdorf was Chief Operating Officer-Bio Medicines at Eli Lilly & Co. from 2001 to 2020.
Mr. Overdorf completed an undergraduate degree at Wabash College in 1992 and earned an MBA from Harvard Business School in 1999.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ANNEXON, INC. 0,11 % | 02/03/2026 | 182.625 ( 0,11 % ) | 989 828 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ANNEXON, INC. | Corporate Officer/Principal | 30/07/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/07/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Wabash College
 Wabash College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
